No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
RANI Rani Therapeutics
- 1.400
- +0.100+7.69%
Close Dec 20 16:00 ET
- 1.420
- +0.020+1.42%
Post 20:01 ET
46.64MMarket Cap-1.33P/E (TTM)
1.415High1.300Low464.14KVolume1.310Open1.300Pre Close635.41KTurnover2.22%Turnover RatioLossP/E (Static)33.31MShares8.75052wk High14.89P/B29.27MFloat Cap1.30052wk Low--Dividend TTM20.91MShs Float36.270Historical High--Div YieldTTM8.85%Amplitude1.300Historical Low1.369Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9
Rani Therapeutics Advances in Biotherapeutics Market
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)
Rani Therapeutics' Weight-Loss Drugs Can Serve Specific Needs -- Market Talk
Rani Therapeutics | 10-Q: Q3 2024 Earnings Report
Rani Therapeutics | 8-K: Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
Heat List
US
Overall
Symbol
Price
% Chg
No Data